<DOC>
	<DOCNO>NCT00240981</DOCNO>
	<brief_summary>The purpose study determine whether testosterone replacement old men low testosterone level increase muscle strength , improve physical performance overall sense well , reduce fatigue .</brief_summary>
	<brief_title>TOM : Testosterone Older Men With Sarcopenia</brief_title>
	<detailed_description>The primary objective study determine whether testosterone replacement old men , low testosterone level mild moderate physical impairment , increase maximal voluntary muscle strength major upper low extremity muscle group . The second objective determine whether testosterone replacement improve power knee extension , physical performance test , level physical activity ( measure 3D accelerometer ) , self-reported disability , exercise tolerance mobility . The third objective determine whether testosterone supplementation improve fatigue , affect , overall sense well old men low testosterone level . A fourth objective define Minimum Clinically Important Differences physical measure perceive participant ( MCID ) . Participant involvement require 15-17 clinic visit 28 week . Five 7 visit physical testing , include body composition , muscle performance , physical function . Throughout study , hormone measurement obtain .</detailed_description>
	<mesh_term>Sarcopenia</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Community dwelling , age 65 older Selfreported difficulty climb 10 step without rest , difficulty walk 2 3 block outside level ground A score 4 9 Short Physical Performance Battery ( mild moderate physical impairment ) Total serum testosterone level ( TT ) &lt; 350 ng/dL &gt; 100 ng/dL Without dementia ( MiniMental State Examination [ MMSE ] score &gt; 24 ) Use testosterone , anabolic steroid , dehydroepiandrosterone ( DHEA ) , androstenedione recombinant growth hormone ( rGH ) past year Alcohol drug abuse Use anticonvulsant glucocorticoid ( equivalent prednisone &gt; 20 mg/day ) Prostate cancer , breast cancer cancer life expectancy &lt; 5 year Limiting neuromuscular , joint bone disease , history stroke residual neurological problem Any neurological condition would impact cognitive function include : epilepsy multiple sclerosis HIV Parkinson 's disease stroke focal lesion Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) Axis I psychiatric disorder past year use psychotropic medication 6 month Abnormal prostate examination ; PSA &gt; 4 ng/mL ; BPH symptom score &gt; 21 Unstable angina , New York ( NY ) class III IV congestive heart failure myocardial infarction within 3 month entry Abnormal laboratory value ( discretion principal investigator ) Untreated thyroid disease ; systolic blood pressure &gt; 160 diastolic &gt; 100 mm Hg Body mass index &gt; 40 kg/m2 Untreated severe obstructive sleep apnea</criteria>
	<gender>Male</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Andropause</keyword>
	<keyword>frailty</keyword>
	<keyword>hormone replacement therapy</keyword>
	<keyword>Aging</keyword>
</DOC>